Skip to main content
. 2017 Dec 27;15(3):3273–3280. doi: 10.3892/ol.2017.7698

Figure 4.

Figure 4.

Serum miR-193b as the most powerful biomarker for predicting chemoradiation sensitivity for ESCC patients. ROC curve analyses were performed on miR-193b (A), miR-942 (B) and miR-629* (C) to evaluate their predictive power for chemoradiation sensitivity in ESCC patients. Both serum miR-193b and miR-942 showed a statistically significant difference.